MUSCLEPHARM CORPORATION

Transcripts MusclePharm Corporation

Equities

MSLP

US6273352012

Market Closed - OTC Markets Other stock markets 12:17:02 2024-07-01 pm EDT			5-day change	1st Jan Change
0.000025 ^USD	+2,400.00%		0.00%	+2,400.00%

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : MusclePharm Corporation, Q1 2022 Earnings Call, May 16, 2022	22-05-16
Transcript : MusclePharm Corporation, Q4 2021 Earnings Call, Apr 14, 2022	22-04-14
MusclePharm Corporation Provides Revenue Guidance for the Fourth Quarter 2021	21-11-16	CI
Transcript : MusclePharm Corporation, Q3 2021 Earnings Call, Nov 15, 2021	21-11-15
Transcript : MusclePharm Corporation, Q2 2021 Earnings Call, Aug 16, 2021	21-08-16
Transcript : MusclePharm Corporation, Q1 2021 Earnings Call, May 24, 2021	21-05-24
Transcript : MusclePharm Corporation, Q3 2018 Earnings Call, Nov 13, 2018	18-11-13
Transcript : MusclePharm Corporation, Q2 2018 Earnings Call, Aug 14, 2018	18-08-14
Transcript : MusclePharm Corporation, Q1 2018 Earnings Call, May 14, 2018	18-05-14
Transcript : MusclePharm Corporation, Q4 2017 Earnings Call, Mar 28, 2018	18-03-28
Transcript : MusclePharm Corporation, Q2 2017 Earnings Call, Aug 14, 2017	17-08-14
Transcript : MusclePharm Corporation Presents at 7th Annual LD Micro Invitational, Jun-06-2017 09:30 AM	17-06-06
Transcript : Muscle Pharm Corp., Q2 2014 Earnings Call, Aug 05, 2014	14-08-05
Muscle Pharm Corp. Announces Unaudited Financial Results for the First Quarter Ended March 31, 2014; Revised Earnings Guidance for 2014	14-05-05	CI
Muscle Pharm Corp. Provides Earnings Outlook for the Full Year of 2013 and 2014	14-01-29	CI
Muscle Pharm Corp. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2012; Provides Earnings Guidance for the Full Year and Final Two Quarters of 2012	12-05-24	CI
Muscle Pharm Corp. Announces Preliminary Earnings Results for the First Quarter Ended March 31, 2012; Provides Sales Guidance for the Year 2012	12-04-23	CI
Muscle Pharm Corp. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2011	12-02-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer